New triple therapy for the diagnosis of CKD-MBD: a cross-sectional study in Shanxi province.

Zhi ZhaoYuanyuan GaoWenDong SuiZiTong ZhangLi FengZhi WangDaihe YangYun ZhouRongshan LiBo Huang

Published in: BMJ open (2024)

The triple combination of β2-microglobulin+parathyroid hormone+blood urea nitrogen indicators can play the crucial role of a sensitive indicator for the early diagnosis of chronic kidney disease-mineral and bone metabolic disorder and in preventing or delaying the progress of chronic kidney disease-mineral and bone metabolic disorder.

Keyphrases

chronic kidney disease
end stage renal disease
bone mineral density
soft tissue
bone loss
bone regeneration
south africa
physical activity
postmenopausal women
peritoneal dialysis
body composition